Large-scale testing (Phase 3)Looking for participantsNCT05485961
What this trial is testing
Combined Dose-Finding and CV Outcomes Study With CSL300 (Clazakizumab) in Adult Subjects With ESKD Undergoing Dialysis
Who this might be right for
Atherosclerotic Cardiovascular DiseaseEnd Stage Kidney DiseaseAtherosclerotic Cardiovascular Disease in Patients With ESKD
CSL Behring 2,310